Tomohira Takeoka

588 total citations
48 papers, 324 citations indexed

About

Tomohira Takeoka is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Tomohira Takeoka has authored 48 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Surgery, 28 papers in Pulmonary and Respiratory Medicine and 16 papers in Oncology. Recurrent topics in Tomohira Takeoka's work include Gastric Cancer Management and Outcomes (22 papers), Esophageal Cancer Research and Treatment (20 papers) and Metastasis and carcinoma case studies (12 papers). Tomohira Takeoka is often cited by papers focused on Gastric Cancer Management and Outcomes (22 papers), Esophageal Cancer Research and Treatment (20 papers) and Metastasis and carcinoma case studies (12 papers). Tomohira Takeoka collaborates with scholars based in Japan. Tomohira Takeoka's co-authors include Yuichiro� Doki, Shinya Urakawa, Masaki Mori, Hisashi Wada, Eiichi Sato, Shuji Takiguchi, Hiroshi Miyata, Kota Iwahori, Shimon Sakaguchi and Takeshi Omori and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Cancer and Annals of Surgical Oncology.

In The Last Decade

Tomohira Takeoka

33 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomohira Takeoka Japan 8 149 143 129 105 39 48 324
Tomohiko Nishi Japan 8 268 1.8× 193 1.3× 94 0.7× 48 0.5× 25 0.6× 20 379
Ryuichiro Sawada Japan 10 192 1.3× 121 0.8× 164 1.3× 21 0.2× 13 0.3× 51 301
Taku Michiura Japan 14 264 1.8× 262 1.8× 182 1.4× 31 0.3× 90 2.3× 47 435
Eric K. Ganguly United States 8 121 0.8× 69 0.5× 153 1.2× 83 0.8× 71 1.8× 23 332
Tadayoshi Hashimoto Japan 10 161 1.1× 170 1.2× 95 0.7× 12 0.1× 35 0.9× 39 277
Jun-Peng Lin China 9 125 0.8× 169 1.2× 162 1.3× 13 0.1× 18 0.5× 23 288
Maoxing Liu China 12 126 0.8× 186 1.3× 146 1.1× 23 0.2× 69 1.8× 31 325
Yusuke Taniyama Japan 12 316 2.1× 246 1.7× 111 0.9× 15 0.1× 43 1.1× 65 468
Luca Pompella Italy 9 106 0.7× 125 0.9× 164 1.3× 18 0.2× 37 0.9× 25 302
Giuseppe Tirino Italy 9 108 0.7× 125 0.9× 161 1.2× 17 0.2× 38 1.0× 24 297

Countries citing papers authored by Tomohira Takeoka

Since Specialization
Citations

This map shows the geographic impact of Tomohira Takeoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohira Takeoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohira Takeoka more than expected).

Fields of papers citing papers by Tomohira Takeoka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohira Takeoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohira Takeoka. The network helps show where Tomohira Takeoka may publish in the future.

Co-authorship network of co-authors of Tomohira Takeoka

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohira Takeoka. A scholar is included among the top collaborators of Tomohira Takeoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohira Takeoka. Tomohira Takeoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tomihara, Hideo, Masahiro Murakami, Masahisa Nakamura, et al.. (2025). Sclerosing angiomatoid nodular transformation mimicking a splenic metastasis from rectal cancer: A case report. Experimental and Therapeutic Medicine. 29(4). 1–5.
4.
Ushimaru, Yuki, Kazuhiro Nishikawa, Ryohei Kawabata, et al.. (2024). A comprehensive study on non-cancer-related mortality risk factors in elderly gastric cancer patients post-curative surgery. BMC Gastroenterology. 24(1). 78–78. 4 indexed citations
5.
Sugase, Takahito, Tomohira Takeoka, Norihiro Matsuura, et al.. (2024). Survival Impact of Inflammation-based Prognostic Scores in Metastatic or Unresectable Esophageal Cancer Treated With Pembrolizumab Plus Chemotherapy. Journal of Immunotherapy. 47(7). 249–257. 3 indexed citations
6.
Takeoka, Tomohira, Takashi Kanemura, Takahito Sugase, et al.. (2024). Clinical impact of postoperative changes in body composition on long-term outcomes in patients with esophageal cancer. Clinical Nutrition. 43(9). 2188–2194.
7.
Takeoka, Tomohira, Kazuyoshi Yamamoto, Yukinori Kurokawa, et al.. (2023). Comparison of the effects of open and laparoscopic approach on body composition in gastrectomy for gastric cancer: A propensity score‐matched study. Annals of Gastroenterological Surgery. 8(1). 40–50. 4 indexed citations
8.
Kawada, Junji, Takuro Saito, Yukinori Kurokawa, et al.. (2023). Serum NY‐ESO‐1 and p53 antibodies as useful tumor markers in gastric cancer. Annals of Gastroenterological Surgery. 8(2). 243–250. 2 indexed citations
9.
Sugase, Takahito, Takashi Kanemura, Tomohira Takeoka, et al.. (2023). Clinical Impact of Enhanced Recovery After Esophagectomy in Patients With Esophageal Cancer. Anticancer Research. 43(9). 4197–4205. 4 indexed citations
10.
Yamamoto, Masaaki, Takeshi Omori, Naoki Shinno, et al.. (2023). Prognostic Value of a Novel Index Combining the Prognostic Nutritional Index and D-Dimer Levels for Gastric Cancer after Gastrectomy. Oncology. 103(1). 1–10. 2 indexed citations
11.
Omori, Takeshi, Naoki Shinno, Hisashi Hara, et al.. (2023). Adjuvant Chemotherapy With S-1 Plus DocetaxelVersusS-1 Plus Oxaliplatin in Stage III Gastric Cancer. Anticancer Research. 43(11). 5015–5024.
12.
13.
Miyata, Hiroshi, Keijiro Sugimura, Takashi Kanemura, et al.. (2022). Salvage Surgery for Recurrent Disease after Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 29(9). 5657–5665. 3 indexed citations
14.
Kanemura, Takashi, Hiroshi Miyata, Tomohira Takeoka, et al.. (2022). Significance of dissection in each regional lymph-node station of esophageal cancer based on efficacy index and recurrence patterns after curative esophagectomy. Esophagus. 20(3). 402–409. 6 indexed citations
15.
Omori, Takeshi, Kazuyoshi Yamamoto, Hisashi Hara, et al.. (2022). Comparison of robotic gastrectomy and laparoscopic gastrectomy for gastric cancer: a propensity score-matched analysis. Surgical Endoscopy. 36(8). 6223–6234. 32 indexed citations
16.
Omori, Takeshi, Hisashi Hara, Naoki Shinno, et al.. (2022). Safety and efficacy of preoperative indocyanine green fluorescence marking in laparoscopic gastrectomy for proximal gastric and esophagogastric junction adenocarcinoma (ICG MAP study). Langenbeck s Archives of Surgery. 407(8). 3387–3396. 7 indexed citations
17.
Sugase, Takahito, Keijiro Sugimura, Takashi Kanemura, et al.. (2022). Recurrence Pattern Comparing Preoperative Chemoradiotherapy and Preoperative Chemotherapy with Docetaxel plus 5-Fluorouracil and Cisplatin for Advanced Esophageal Cancer. Oncology. 100(12). 655–665. 7 indexed citations
18.
Miyata, Hiroshi, Keijirou Sugimura, Tomohira Takeoka, et al.. (2021). Clinical Outcome of Additional Esophagectomy After Endoscopic Treatment for Superficial Esophageal Cancer. Annals of Surgical Oncology. 28(12). 7230–7239. 7 indexed citations
19.
Murata, Kohei, Shu Okamura, Hirofumi Okubo, et al.. (2013). [Neoadjuvant chemoradiotherapy with capecitabine and oxaliplatin for the treatment of locally advanced lower rectal cancer].. PubMed. 40(12). 2020–2. 2 indexed citations
20.
Okada, Kazuyuki, Yuma Wada, Ryo Kato, et al.. (2013). [A case of jejunum cancer diagnosed by anemia].. PubMed. 40(12). 1720–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026